AVCR.F Stock Overview
Engages in the health data and point-of-care technologies business in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Avricore Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.045 |
| 52 Week High | CA$0.25 |
| 52 Week Low | CA$0.038 |
| Beta | -1.9 |
| 11 Month Change | -61.19% |
| 3 Month Change | -81.44% |
| 1 Year Change | -68.16% |
| 33 Year Change | -61.96% |
| 5 Year Change | 98.88% |
| Change since IPO | -96.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVCR.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -1.0% | 2.1% | 2.2% |
| 1Y | -68.2% | 8.2% | 31.6% |
Return vs Industry: AVCR.F underperformed the US Healthcare Services industry which returned 8.2% over the past year.
Return vs Market: AVCR.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| AVCR.F volatility | |
|---|---|
| AVCR.F Average Weekly Movement | 26.0% |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AVCR.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine AVCR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018.
Avricore Health Inc. Fundamentals Summary
| AVCR.F fundamental statistics | |
|---|---|
| Market cap | US$4.33m |
| Earnings (TTM) | -US$2.09k |
| Revenue (TTM) | US$3.20m |
1.4x
P/S Ratio-2,075x
P/E RatioIs AVCR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVCR.F income statement (TTM) | |
|---|---|
| Revenue | CA$4.48m |
| Cost of Revenue | CA$2.86m |
| Gross Profit | CA$1.62m |
| Other Expenses | CA$1.62m |
| Earnings | -CA$2.92k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.000029 |
| Gross Margin | 36.16% |
| Net Profit Margin | -0.065% |
| Debt/Equity Ratio | 0% |
How did AVCR.F perform over the long term?
See historical performance and comparison